These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19299556)

  • 1. Bladder cancer: modeling and translation.
    Rosenberg JE; Hahn WC
    Genes Dev; 2009 Mar; 23(6):655-9. PubMed ID: 19299556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of gene expression patterns in superficial and invasive human bladder cancers].
    Zhou L; Shi BT; Wang SX; Luo Y; Yang L; Zhang LL; Wang XY; He DL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):798-801. PubMed ID: 17565857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
    Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
    Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
    Sugano K; Kakizoe T
    Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers for detection, surveillance and prognostication of bladder cancer.
    Vrooman OP; Witjes JA
    Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.
    Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO
    Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in bladder cancer diagnostics.
    Sanchez-Carbayo M
    Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
    Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
    Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
    Wang XS; Zhang Z; Wang HC; Cai JL; Xu QW; Li MQ; Chen YC; Qian XP; Lu TJ; Yu LZ; Zhang Y; Xin DQ; Na YQ; Chen WF
    Clin Cancer Res; 2006 Aug; 12(16):4851-8. PubMed ID: 16914571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic aspects of bladder cancer.
    Kim WJ; Quan C
    J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
    Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
    J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
    Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
    Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of invasive bladder cancers: histological and molecular markers.
    Liebert M; Seigne J
    Semin Urol Oncol; 1996 May; 14(2):62-72. PubMed ID: 8734733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
    Ahmed HU; Arya M; Patel HR
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1011-22. PubMed ID: 16336092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors of urinary bladder carcinoma].
    vom Dorp F; Jaeger T; Schmidt K; Siffert W; Rübben H
    Urologe A; 2007 Sep; 46(9):1151. PubMed ID: 17641868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.